Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7171)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2014 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Zhang Y, Hu XY, Zhong S, Yang F, Zhou TY, Chen G, Wang YY, Luo JX. Entecavir |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i16/4745.htm |
| Number | Citing Articles |
| 1 |
Wei-Lun Tsai, Wei-Chi Sun, Jin-Shiung Cheng. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. International Journal of Molecular Sciences 2015; 16(12): 28126 doi: 10.3390/ijms161226087
|
| 2 |
Jiao Yang, Hang Sun, Qi Liu. The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/5802674
|
| 3 |
Yue-Meng Wan, Yu-Hua Li, Zhi-Yuan Xu, Hua-Mei Wu, Ying Xu, Xi-Nan Wu, Jin-Hui Yang. Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C. Journal of Clinical Gastroenterology 2019; 53(4): e171 doi: 10.1097/MCG.0000000000001038
|
| 4 |
Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091
|
| 5 |
Wan Yue-Meng, Li-Hong Yang, Jin-Hui Yang, Ying Xu, Jing Yang, Gui-Bo Song. The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure. Hepatology International 2016; 10(3): 462 doi: 10.1007/s12072-015-9667-4
|
| 6 |
Anna S.F. Lok, Brian J. McMahon, Robert S. Brown, John B. Wong, Ahmed T. Ahmed, Wigdan Farah, Jehad Almasri, Fares Alahdab, Khalid Benkhadra, Mohamed A. Mouchli, Siddharth Singh, Essa A. Mohamed, Abd Moain Abu Dabrh, Larry J. Prokop, Zhen Wang, Mohammad Hassan Murad, Khaled Mohammed. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis. Hepatology 2016; 63(1): 284 doi: 10.1002/hep.28280
|
| 7 |
Guiqiang Wang, Zhongping Duan. Guidelines for Prevention and Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00209
|
| 8 |
Ruma Rajbhandari, Raymond T Chung. Treatment of Hepatitis B: A Concise Review. Clinical and Translational Gastroenterology 2016; 7(9): e190 doi: 10.1038/ctg.2016.46
|
| 9 |
S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. L. Y. Chan, C. J. Chen, D. S. Chen, H. L. Chen, P. J. Chen, R. N. Chien, A. K. Dokmeci, Ed Gane, J. L. Hou, W. Jafri, J. Jia, J. H. Kim, C. L. Lai, H. C. Lee, S. G. Lim, C. J. Liu, S. Locarnini, M. Al Mahtab, R. Mohamed, M. Omata, J. Park, T. Piratvisuth, B. C. Sharma, J. Sollano, F. S. Wang, L. Wei, M. F. Yuen, S. S. Zheng, J. H. Kao. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology International 2016; 10(1): 1 doi: 10.1007/s12072-015-9675-4
|
| 10 |
Geoffrey Dusheiko. Current and Future Directions of Management of Hepatitis B: Steps Toward a Cure. Future Virology 2018; 13(3): 189 doi: 10.2217/fvl-2017-0103
|
| 11 |
Jinlin Hou, Guiqiang Wang, Fusheng Wang, Jun Cheng, Hong Ren, Hui Zhuang, Jian Sun, Lanjuan Li, Jie Li, Qinghua Meng, Jingmin Zhao, Zhongping Duan, Jidong Jia, Hong Tang, Jifang Sheng, Jie Peng, Fengmin Lu, Qing Xie, Lai Wei. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). Journal of Clinical and Translational Hepatology 2017; 5(4): 297 doi: 10.14218/JCTH.2016.00019
|
| 12 |
Hidemi Hayashi, Koji Sawada, Takumu Hasebe, Syunsuke Nakajima, Masami Abe, Yayoi Hosoki, Takaaki Ohtake, Tsuneshi Fujii, Mikihiro Fujiya, Yutaka Kohgo, Chitomi Hasebe. Conservative treatment of lamivudine-induced rhabdomyolysis in a patient with acute exacerbation of chronic hepatitis B. Kanzo 2015; 56(7): 341 doi: 10.2957/kanzo.56.341
|
| 13 |
Kuang-Wei Huang, Ka-Wai Tam, Jiing-Chyuan Luo, Yi-Chun Kuan. Efficacy and Safety of Lamivudine Versus Entecavir for Treating Chronic Hepatitis B Virus–related Acute Exacerbation and Acute-on-Chronic Liver Failure. Journal of Clinical Gastroenterology 2017; 51(6): 539 doi: 10.1097/MCG.0000000000000675
|
| 14 |
Yang Zhang, Yi-Tong Wang, Jian-Xing Luo, Xiao-Yu Hu, Fang Yang, Wu Lin, Xiao Liang, Bing-Jie Zhao, Song Zhang, Yuan-Yuan Chen. Effect of WSP, a Chinese Herbal Formula, on Th17/Treg Ratio and HBeAg Seroconversion in Telbivudine-Treated HBeAg-Positive Chronic Hepatitis B Patients with High Baseline ALT Levels (20–30 Times the ULN). Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/7260369
|
| 15 |
Yang Xiang-hui, Xiao Lang, Zhang Yan, Zhang Li, Shi Xiao-feng, Ren Hong. Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: Using virologic response at week 4. European Journal of Internal Medicine 2014; 25(9): 860 doi: 10.1016/j.ejim.2014.10.007
|
| 16 |
Juan Li, Chunhua Hu, Yi Chen, Rou Zhang, Shan Fu, Mimi Zhou, Zhijie Gao, Mengjun Fu, Taotao Yan, Yuan Yang, Jianzhou Li, Jinfeng Liu, Tianyan Chen, Yingren Zhao, Yingli He. Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06237-x
|
| 17 |
Lubiao Chen, Dujing Bao, Lin Gu, Yurong Gu, Liang Zhou, Zhiliang Gao, Yuehua Huang. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3192-8
|
| 18 |
Jian-Xing Luo, Yang Zhang, Xiao-Yu Hu, Chang Yu. The Effect of Modified Sini Decoction on Survival Rates of Patients with Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/2501847
|
| 19 |
Xiaoshu Li, Fangyuan Gao, Huimin Liu, Henghui Zhang, Yao Liu, Xieqiong Ye, Mingfan Geng, Le Sun, Rui Wang, Yuxin Li, Yuyong Jiang, Xiaojing Wang, Guiqin Zhou, Zhiyun Yang, Ang Li, Hui Zeng, Xianbo Wang. Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score. European Journal of Gastroenterology & Hepatology 2017; 29(1): 1 doi: 10.1097/MEG.0000000000000750
|
| 20 |
Chen Li, Bing Zhu, Sa Lv, Shaoli You, Shaojie Xin. Prediction model of the progression of patients with acute deterioration of hepatitis B virus-related chronic liver disease to acute-on-chronic liver failure. Medicine 2018; 97(34): e11915 doi: 10.1097/MD.0000000000011915
|
| 21 |
Jian Wu, Fang Yin, Xinmin Zhou. Efficacy of nucleoside analogues for hepatitis B virus-related liver failure: A network meta-analysis. Acta Pharmaceutica 2018; 68(1): 19 doi: 10.2478/acph-2018-0010
|
| 22 |
Yuting Chen, Jingkang Sun, Xiude Fan, Xiaoyun Wang, Lu Zeng, Xiaoge Zhang, Kun Zhang, Na Li, Qunying Han, Zhengwen Liu. Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.648736
|
| 23 |
Man-Fung Yuen. Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure. Hepatology International 2015; 9(3): 373 doi: 10.1007/s12072-014-9569-x
|
| 24 |
Chih-Yang Lin, Wei-Chih Sun, Chia-Ming Lu, Wen-Chi Chen, Feng-Woei Tsay, Tzun-Jiun Tsai, Feng-Yu Kuo, Wei-Lun Tsai. Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis B patients with severe acute exacerbation. European Journal of Gastroenterology & Hepatology 2024; 36(9): 1113 doi: 10.1097/MEG.0000000000002709
|
| 25 |
涓 杨. Prediction of Model for End-Stage Liver Disease Combined with Serum Alpha-Fetoprotein and Cholinesterase Levels on the Short-Term Prognosis in Patients with Acute-on-Chronic Hepatitis B Liver Failure. Advances in Clinical Medicine 2018; 8(02): 107 doi: 10.12677/ACM.2018.82019
|
| 26 |
Hiroshi Kamitsukasa, Masanobu Iri, Akihisa Tanaka, Shigeo Nagashima, Masaharu Takahashi, Tsutomu Nishizawa, Hiroaki Okamoto. Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection. Journal of Medical Virology 2015; 87(4): 589 doi: 10.1002/jmv.24115
|
| 27 |
Paolo Angeli, Mauro Bernardi, Càndid Villanueva, Claire Francoz, Rajeshwar P. Mookerjee, Jonel Trebicka, Aleksander Krag, Wim Laleman, Pere Gines. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology 2018; 69(2): 406 doi: 10.1016/j.jhep.2018.03.024
|
| 28 |
Ying Zheng, Shu Chen, Yanxin Huang, Lisheng Jiang, Yongguo Li, Yinghua Lan, Shuchen Li, Yuqin Xu, Xiaodong Li, Hongwei Zhao, Yanbo Wang, Ying Shen, Chao Wei, Honglin Zhou, Rongshan Fan, Xiqiu Zeng, Mingxia Jiang, Shupeng Song, Mingyan Xu. Prevalence and Severity of HBV-Associated Acute-on-Chronic Liver Failure Due to Irregular Medication of Nucleos(t)ide Analogs. Infectious Microbes and Diseases 2021; 3(4): 205 doi: 10.1097/IM9.0000000000000076
|